Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ian Phillips
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Disorders
Procedures
Anatomy
Sign-in to see full Profile
Network (preview)
11
Kimura, B
11
Raizada, Mohan
10
Sumners, Colin
9
Bui, Jonathan
9
Kagiyama, Shuntaro
8
Mohuczy, Dagmara
6
Buckley, David
5
Blackband, Stephen
5
Galli, SM
5
Mehta, Jawahar
5
Wielbo, D
5
Qian, Keping
5
Zhang, Clare
4
Zelles, Tibor
4
Richards, Elaine
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ian Phillips (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2004: Kagiyama Tomoko; Glushakov Alexander V; Sumners Colin; Roose Brandy; Dennis Donn M; Phillips M Ian; Ozcan Mehmet S; Seubert Christoph N; Martynyuk Anatoly E
Neuroprotective action of halogenated derivatives of L-phenylalanine.
Stroke; a journal of cerebral circulation 2004;35(5):1192-6.
-
2003: Kagiyama Shuntaro; Qian Keping; Kagiyama Tomoko; Phillips M Ian
Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy.
Hypertension 2003;41(3 Pt 2):824-9.
-
2003: Kagiyama Tomoko; Kagiyama Shuntaro; Phillips M Ian
Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats.
Regulatory peptides 2003;110(3):241-7.
-
2002: Mohuczy Dagmara; Qian Keping; Phillips M Ian
Presenilins in the heart: presenilin-2 expression is increased by low glucose and by hypoxia in cardiac cells.
Regulatory peptides 2002;110(1):1-7.
-
2002: Tang Yi; Schmitt-Ott Kai; Qian Keping; Kagiyama Shuntaro; Phillips M Ian
Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases.
Methods (San Diego, Calif.) 2002;28(2):259-66.
-
2002: Kagiyama Shuntaro; Eguchi Satoru; Frank Gerald D; Inagami Tadashi; Zhang Yuan Clare; Phillips M Ian
Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense.
Circulation 2002;106(8):909-12.
-
2002: Phillips M Ian; Kagiyama Shuntaro
Angiotensin II as a pro-inflammatory mediator.
Current opinion in investigational drugs (London, England : 2000) 2002;3(4):569-77.
-
2002: Tang Yi; Jackson MaShira; Qian Keping; Phillips M Ian
Hypoxia inducible double plasmid system for myocardial ischemia gene therapy.
Hypertension 2002;39(2 Pt 2):695-8.
-
2002: Phillips M Ian; Tang Yi; Schmidt-Ott Kai; Qian Keping; Kagiyama Shuntaro
Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection.
Hypertension 2002;39(2 Pt 2):651-5.
-
2002: Phillips M Ian
Gene therapy for hypertension: the preclinical data.
Methods in enzymology 2002;346():3-13.
-
2001: Galli S M; Phillips M I
Angiotensin II AT(1A) receptor antisense lowers blood pressure in acute 2-kidney, 1-clip hypertension.
Hypertension 2001;38(3 Pt 2):674-8.
-
2001: Phillips M I
Gene therapy for hypertension: the preclinical data.
Hypertension 2001;38(3 Pt 2):543-8.
-
2001: Phillips M I
Gene therapy for hypertension: sense and antisense strategies.
Expert opinion on biological therapy 2001;1(4):655-62.
-
2001: Kagiyama S; Kagiyama T; Phillips M I
Antisense oligonucleotides strategy in the treatment of hypertension.
Current opinion in molecular therapeutics 2001;3(3):258-64.
-
2001: Peng J F; Phillips M I
Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension.
Regulatory peptides 2001;97(2-3):91-102.
-
2001: Kimura B; Mohuczy D; Tang X; Phillips M I
Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense.
Hypertension 2001;37(2 Part 2):376-80.
-
2001: Kagiyama S; Varela A; Phillips M I; Galli S M
Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats.
Hypertension 2001;37(2 Part 2):371-5.
-
2000: Mohuczy D; Phillips M I
Antisense inhibition of the renin-angiotensin system in brain and peripheral organs.
Methods (San Diego, Calif.) 2000;22(3):197-209.
-
2000: Mohuczy D; Phillips M I
Designing antisense to inhibit the renin-angiotensin system.
Molecular and cellular biochemistry 2000;212(1-2):145-53.
-
2000: Schmidt-Ott K M; Kagiyama S; Phillips M I
The multiple actions of angiotensin II in atherosclerosis.
Regulatory peptides 2000;93(1-3):65-77.
-
2000: Phillips M I; Galli S M; Mehta J L
The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.
Drugs 2000;60(2):239-48.
-
2000: Chen H; Zhang Y C; Li D; Phillips M I; Mehta P; Shi M; Mehta J L
Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
The Journal of pharmacology and experimental therapeutics 2000;294(2):722-7.
-
2000: Phillips M I
Somatic gene therapy for hypertension.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2000;33(6):715-21.
-
2000: Bavry A A; Li D; Zander D S; Phillips M I; Mehta J L
Inhibition of arterial thrombogenesis by quinapril but not losartan.
Journal of cardiovascular pharmacology and therapeutics 2000;5(2):121-7.
-
2000: Zhang Y C; Bui J D; Shen L; Phillips M I
Antisense inhibition of beta(1)-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats.
Circulation 2000;101(6):682-8.
-
2000: Clare Zhang Y; Kimura B; Shen L; Phillips M I
New beta-blocker: prolonged reduction in high blood pressure with beta(1) antisense oligodeoxynucleotides.
Hypertension 2000;35(1 Pt 2):219-24.
-
2000: Phillips M I; Zhang Y C
Basic principles of using antisense oligonucleotides in vivo.
Methods in enzymology 2000;313():46-56.
-
2000: Mohuczy D; Tang X; Phillips M I
Delivery of antisense DNA by vectors for prolonged effects in vitro and in vivo.
Methods in enzymology 2000;314():32-51.
-
1999: Blackband S J; Buckley D L; Bui J D; Phillips M I
NMR microscopy--beginnings and new directions.
Magma (New York, N.Y.) 1999;9(3):112-6.
-
1999: Tang X; Mohuczy D; Zhang Y C; Kimura B; Galli S M; Phillips M I
Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension.
The American journal of physiology 1999;277(6 Pt 2):H2392-9.
-
1999: Wang H; Katovich M J; Gelband C H; Reaves P Y; Phillips M I; Raizada M K
Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA.
Circulation research 1999;85(7):614-22.
-
1999: Buckley D L; Bui J D; Phillips M I; Blackband S J
MRI measurement of cell volume fraction in the perfused rat hippocampal slice.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1999;42(3):603-7.
-
1999: Bui J D; Zelles T; Lou H J; Gallion V L; Phillips M I; Tan W
Probing intracellular dynamics in living cells with near-field optics.
Journal of neuroscience methods 1999;89(1):9-15.
-
1999: Bui J D; Nammari D R; Buckley D L; Inglis B A; Silver X S; Mareci T H; Phillips M I
In vivo dynamics and distribution of intracerebroventricularly administered gadodiamide, visualized by magnetic resonance imaging.
Neuroscience 1999;90(3):1115-22.
-
1999: Buckley D L; Bui J D; Phillips M I; Zelles T; Inglis B A; Plant H D; Blackband S J
The effect of ouabain on water diffusion in the rat hippocampal slice measured by high resolution NMR imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1999;41(1):137-42.
-
1999: Mohuczy D; Gelband C H; Phillips M I
Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector.
Hypertension 1999;33(1 Pt 2):354-9.
-
1999: Bui J D; Buckley D L; Phillips M I; Blackband S J
Nuclear magnetic resonance imaging measurements of water diffusion in the perfused hippocampal slice during N-methyl-D-aspartate-induced excitotoxicity.
Neuroscience 1999;93(2):487-90.
-
1998: Phillips M I; Sumners C
Angiotensin II in central nervous system physiology.
Regulatory peptides 1998;78(1-3):1-11.
-
1998: Phillips M I
Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1-receptor messenger ribonucleic acid.
The American journal of cardiology 1998;82(10A):60S-62S.
-
1998: Yang B C; Phillips M I; Mohuczy D; Meng H; Shen L; Mehta P; Mehta J L
Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(9):1433-9.
-
1998: Yang B C; Phillips M I; Zhang Y C; Kimura B; Shen L P; Mehta P; Mehta J L
Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
Circulation research 1998;83(5):552-9.
-
1998: Peng J F; Kimura B; Fregly M J; Phillips M I
Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood.
Hypertension 1998;31(6):1317-23.
-
1998: Yang B; Li D; Phillips M I; Mehta P; Mehta J L
Myocardial angiotensin II receptor expression and ischemia-reperfusion injury.
Vascular medicine (London, England) 1998;3(2):121-30.
-
1997: Blackband S J; Bui J D; Buckley D L; Zelles T; Plant H D; Inglis B A; Phillips M I
MR microscopy of perfused brain slices.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1997;38(6):1012-5.
-
1997: Li B; Hughes J A; Phillips M I
Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells.
Neurochemistry international 1997;31(3):393-403.
-
1997: Yang B C; Phillips M I; Ambuehl P E; Shen L P; Mehta P; Mehta J L
Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts.
Circulation 1997;96(3):922-6.
-
1997: Gyurko R; Tran D; Phillips M I
Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats.
American journal of hypertension 1997;10(5 Pt 2):56S-62S.
-
1997: Phillips M I; Mohuczy-Dominiak D; Coffey M; Galli S M; Kimura B; Wu P; Zelles T
Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense.
Hypertension 1997;29(1 Pt 2):374-80.
-
1997: Phillips M I
Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Hypertension 1997;29(1 Pt 2):177-87.
-
1996: Phillips M I; Heininger F; Toffolo S
The role of brain angiotensin in thirst and AVP release induced by hemorrhage.
Regulatory peptides 1996;66(1-2):3-11.
-
1996: Wielbo D; Simon A; Phillips M I; Toffolo S
Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides.
Hypertension 1996;28(1):147-51.
-
1996: Phillips M I; Ambühl P; Gyurko R
Antisense oligonucleotides for in vivo studies of angiotensin receptors.
Advances in experimental medicine and biology 1996;396():79-92.
-
1995: Ambühl P; Gyurko R; Phillips M I
A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor.
Regulatory peptides 1995;59(2):171-82.
-
1995: Phillips M I; Gyurko R
In vivo applications of antisense oligonucleotides for peptide research.
Regulatory peptides 1995;59(2):131-41.
-
1995: Wielbo D; Sernia C; Gyurko R; Phillips M I
Antisense inhibition of hypertension in the spontaneously hypertensive rat.
Hypertension 1995;25(3):314-9.
-
1995: Phillips M I; Wang H; Kimura B; Speth R C; Ghazi N
Brain angiotensin and the female reproductive cycle.
Advances in experimental medicine and biology 1995;377():357-70.
-
1994: Meng H; Wielbo D; Gyurko R; Phillips M I
Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin.
Regulatory peptides 1994;54(2-3):543-51.
-
1994: Phillips M I; Wielbo D; Gyurko R
Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes.
Kidney international 1994;46(6):1554-6.
-
1994: Dawson R; Felheim R; Phillips M I
Characterization of the synthesis and release of dopamine in LLC-PK1 cells.
Renal physiology and biochemistry 1994;17(2):85-100.
-
1994: Hogarty D C; Tran D N; Phillips M I
Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin.
Brain research 1994;637(1-2):126-32.
-
1993: Gyurko R; Wielbo D; Phillips M I
Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin.
Regulatory peptides 1993;49(2):167-74.
-
1993: Dawson R; Felheim R; Phillips M I
Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells.
European journal of pharmacology 1993;240(2-3):277-82.
-
1993: Cook M D; Phillips M I; Cook V I; Kimura B; Wilcox C S
Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism.
Journal of the American Society of Nephrology : JASN 1993;4(1):111-6.
-
1993: Richards E M; Lu D; Zelezna B; Phillips M I; Trolliet M; Sumners C; Raizada M K
Inhibition of central angiotensin responses by angiotensin type-1 receptor antibody.
Hypertension 1993;21(6 Pt 2):1062-5.
-
1993: Phillips M I; Wang H; Kimura B; Rejtman M; Koduri P; Kalra S P
Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge.
Endocrinology 1993;132(4):1637-42.
-
1993: Phillips M I; Shen L; Richards E M; Raizada M K
Immunohistochemical mapping of angiotensin AT1 receptors in the brain.
Regulatory peptides 1993;44(2):95-107.
-
1993: Phillips M I; Speakman E A; Kimura B
Levels of angiotensin and molecular biology of the tissue renin angiotensin systems.
Regulatory peptides 1993;43(1-2):1-20.
-
1992: Braith R W; Wood C E; Limacher M C; Pollock M L; Lowenthal D T; Phillips M I; Staples E D
Abnormal neuroendocrine responses during exercise in heart transplant recipients.
Circulation 1992;86(5):1453-63.
-
1992: Kimura B; Sumners C; Phillips M I
Changes in skin angiotensin II receptors in rats during wound healing.
Biochemical and biophysical research communications 1992;187(2):1083-90.
-
1992: Bui J D; Kimura B; Phillips M I
Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
European journal of pharmacology 1992;219(1):147-51.
-
1992: Gyurko R; Kimura B; Kurian P; Crews F T; Phillips M I
Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices.
Biochemical and biophysical research communications 1992;186(1):285-92.
-
1992: Hogarty D C; Speakman E A; Puig V; Phillips M I
The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
Brain research 1992;586(2):289-94.
-
1992: Fannon L D; Braylan R C; Phillips M I
Alterations of lymphocyte populations during development in the spontaneously hypertensive rat.
Journal of hypertension 1992;10(7):629-34.
-
1992: Trolliet M R; Phillips M I
The effect of chronic bilateral nephrectomy on plasma and brain angiotensin.
Journal of hypertension 1992;10(1):29-36.
-
1992: Fannon L D; Phillips M I
White blood cell and lymphocyte populations following interleukin-2 administration in the spontaneously hypertensive rat.
Clinical and experimental hypertension. Part A, Theory and practice 1992;14(6):1111-23.
-
1991: Fannon L D; Phillips M I
Chronic ICV infusion of neuropeptides alters lymphocyte populations in experimental rodents.
Regulatory peptides 1991;34(3):189-95.
-
1991: Cononie C C; Graves J E; Pollock M L; Phillips M I; Sumners C; Hagberg J M
Effect of exercise training on blood pressure in 70- to 79-yr-old men and women.
Medicine and science in sports and exercise 1991;23(4):505-11.
-
1990: Dawson R; Phillips M I
Dopamine synthesis and release in LLC-PK1 cells.
European journal of pharmacology 1990;189(6):423-6.
-
1990: MacLean M R; Phillips M I; Sumners C; Raizada M K
Alpha-1-adrenergic receptors in the nucleus tractus solitarii region of rats with experimental and genetic hypertension.
Brain research 1990;519(1-2):261-5.
-
1990: Garg L C; Wozniak M; Phillips M I
Stimulation of phosphoinositide hydrolysis by oxytocin in renal epithelial cells.
The Journal of pharmacology and experimental therapeutics 1990;252(2):552-7.
-
1990: Raizada M K; Kimura B; Phillips M I
Immunoreactive atrial natriuretic peptide in neuronal and glial cells of spontaneously hypertensive rat brain.
The American journal of physiology 1990;258(1 Pt 1):C109-14.
-
1989: Phillips M I; Kimura B; Wang H; Hoffman W E
Effect of vagotomy on brain and plasma atrial natriuretic peptide during hemorrhage.
The American journal of physiology 1989;257(6 Pt 2):R1393-9.
-
1989: Richards E M; Hermann K; Sumners C; Raizada M K; Phillips M I
Release of immunoreactive angiotensin II from neuronal cultures: adrenergic influences.
The American journal of physiology 1989;257(3 Pt 1):C588-95.
-
1989: Richards E M; Sumners C; Chou Y C; Raizada M K; Phillips M I
Alpha 2-adrenergic receptors in neuronal and glial cultures: characterization and comparison.
Journal of neurochemistry 1989;53(1):287-96.
-
1989: Hermann K; Phillips M I; Raizada M K
Metabolism of angiotensin peptides by neuronal and glial cultures from rat brain.
Journal of neurochemistry 1989;52(3):863-8.
-
1989: Wilcox C S; Smith T B; Frederickson E D; Wingo C D; Phillips M I; Williams C M
The captopril glomerular filtration rate renogram in renovascular hypertension.
Clinical nuclear medicine 1989;14(1):1-7.
-
1988: Garg L C; Kapturczak E; Steiner M; Phillips M I
Vasopressin stimulates phosphoinositide hydrolysis in LLC-PK1 cells.
The American journal of physiology 1988;255(4 Pt 1):C502-7.
-
1988: Anke J; Van Eekelen M; Phillips M I
Plasma angiotensin II levels at moment of drinking during angiotensin II intravenous infusion.
The American journal of physiology 1988;255(3 Pt 2):R500-6.
-
1988: Hermann K; Phillips M I; Hilgenfeldt U; Raizada M K
Biosynthesis of angiotensinogen and angiotensins by brain cells in primary culture.
Journal of neurochemistry 1988;51(2):398-405.
-
1988: Phillips M I; Kimura B
Brain angiotensin in the developing spontaneously hypertensive rat.
Journal of hypertension 1988;6(8):607-12.
-
1988: Steiner M; Phillips M I
Renal tubular vasopressin receptors downregulated by dehydration.
The American journal of physiology 1988;254(3 Pt 1):C404-10.
-
1988: Hermann K; Raizada M K; Sumners C; Phillips M I
Immunocytochemical and biochemical characterization of angiotensin I and II in cultured neuronal and glial cells from rat brain.
Neuroendocrinology 1988;47(2):125-32.
-
1987: Hermann K; Raizada M K; Sumners C; Phillips M I
Presence of renin in primary neuronal and glial cells from rat brain.
Brain research 1987;437(2):205-13.
Sign-in to see more